Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optical assessment of pharmacodynamic responses to vasoactive drugs delivered by iontophoresis in healthy volunteers
2018-004624-11Phase 2Active
- Sponsor
- Region Östergötland
- Start
- Jan 2019
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of acetylcholine, sodium nitroprusside, norepinephrine, phenylephrine, atropine and 1 more, sponsored by Region Östergötland. Primary endpoints: ED50 (dose producing 50% of maximal effect), Minimum response value and 2 more. Started Jan 2019; status: active.
02
Drugs
acetylcholinesodium nitroprussidenorepinephrinephenylephrineatropine
Beyond the preview
Go deeper on 2018-004624-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004624-11.